Skip to main content
SpringerLink
Log in

A case of MOG antibody-associated disease with selective positivity in cerebrospinal fluid using IgG-Fc cell-based assay

  • Letter to the Editor
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Tzartos JS, Karagiorgou K, Tzanetakos D et al (2020) Deciphering anti-MOG IgG antibodies: clinical and radiological spectrum, and comparison of antibody detection assays. J Neurol Sci 410:116673. https://doi.org/10.1016/j.jns.2020.116673

    Article  CAS  PubMed  Google Scholar 

  2. Gastaldi M, Scaranzin S, Jarius S et al (2020) Cell-based assays for the detection of MOG antibodies: a comparative study. J Neurol 267:3555–3564. https://doi.org/10.1007/s00415-020-10024-0

    Article  CAS  PubMed  Google Scholar 

  3. Akaishi T, Takahashi T, Misu T et al (2021) Difference in the source of anti-AQP4-IgG and anti-MOG-IgG antibodies in CSF in patients with neuromyelitis optica spectrum disorder. Neurology 97:e1–e12. https://doi.org/10.1212/WNL.0000000000012175

    Article  PubMed  PubMed Central  Google Scholar 

  4. Banwell B, Bennett JL, Marignier R et al (2023) Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria. Lancet Neurol 22:268–282. https://doi.org/10.1016/S1474-4422(22)00431-8

    Article  CAS  PubMed  Google Scholar 

  5. Sechi E, Krecke KN, Pittock SJ et al (2021) Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies. Mult Scler 27:303–308. https://doi.org/10.1177/1352458520907900

    Article  CAS  PubMed  Google Scholar 

  6. Kaneko K, Sato DK, Nakashima I et al (2018) CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications. J Neurol Neurosurg Psychiatry 89:927–936. https://doi.org/10.1136/jnnp-2018-317969

    Article  PubMed  Google Scholar 

Download references

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology and Therapeutics, Ehime University Graduate School of Medicine, 454 Shidukawa, Tohon, Ehime, 791-0295, Japan

    Noriyuki Miyaue & Masahiro Nagai

  2. Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan

    Kimihiko Kaneko & Toshiyuki Takahashi

  3. Department of Neurology, National Hospital Organization Yonezawa National Hospital, Yonezawa, Yamagata, Japan

    Toshiyuki Takahashi

Authors
  1. Noriyuki Miyaue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kimihiko Kaneko
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Toshiyuki Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masahiro Nagai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Noriyuki Miyaue.

Ethics declarations

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical approval

The patient provided informed consent for publication. The authors confirm that the approval of an institutional review board was not required for this work.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miyaue, N., Kaneko, K., Takahashi, T. et al. A case of MOG antibody-associated disease with selective positivity in cerebrospinal fluid using IgG-Fc cell-based assay. Acta Neurol Belg 124, 683–685 (2024). https://doi.org/10.1007/s13760-023-02379-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-023-02379-8

Keyword

Search

Navigation